Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
about
Response criteria of tolvaptan for the treatment of hepatic edema.Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study).
P2860
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@en
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@nl
type
label
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@en
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@nl
prefLabel
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@en
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
@en
P2093
Hirofumi Higashi
Hirofumi Uto
Ichiro Kanetsuki
Koki Tokunaga
Kotaro Kumagai
Osamu Kubozono
Seiichi Mawatari
Shigeho Maenohara
P2860
P304
P356
10.1111/HEPR.12778
P577
2016-07-23T00:00:00Z